China Banks Halt New Loans to Sanctioned Refineries Amid U.S.-Iran Oil Crackdown 
AMD Q1 Earnings Surge on AI Demand, Stock Jumps After Strong Guidance 
Orsted Q1 EBITDA Beats Expectations Despite U.S. Impairments 
OCBC Q1 Profit Rises 5% on Strong Wealth Management and Non-Interest Income 
Hua Hong Semiconductor Stock Surges to Multi-Year High Amid AI Boom 
BHP Attracts AI-Focused Investors as Copper Demand Surges 
Intel Emerges as Key Contender in Apple’s Chip Manufacturing Strategy Shift 
Coinbase Q1 2026 Earnings Miss Sends COIN Stock Lower Amid Crypto Market Slump 
Aker BP Q1 Profit Jumps on Higher Oil Prices and Asset Reversal 
Strategy Reports Q1 Loss as Bitcoin Holdings Trigger $14.46 Billion Unrealized Hit 
BMW Keeps 2026 Outlook Despite 25% Profit Drop Amid Tariff Pressure 
Infineon Raises 2026 Outlook as AI Data Center Chip Demand Surges 
AWS Data Center Overheating Disrupts Cloud Services in Northern Virginia 
Trump Invites Top CEOs Including Nvidia, Apple, Boeing to China Summit With Xi Jinping 
Philips Reaffirms 2026 Outlook After Strong Q1 Sales and Margin Beat 
Shell Q1 Profit Surges to Two-Year High as Dividend Rises Despite War-Driven Debt Pressure 
JD Sports Backs Nike CEO Elliott Hill Amid Brand Turnaround Efforts 
MEDFORD, N.Y., April 26, 2018 -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care diagnostic tests for infectious diseases, announced today that it will release financial results for the first quarter 2018 after the close of trading on Wednesday, May 9, 2018. The Company’s management team will host a corresponding conference call beginning at 4:30 pm ET.
Investors interested in listening to the conference call may do so by dialing 877-407-0778 from the US or 201-689-8565 from outside the US. A live and archived webcast of the event will be available on the “Investors” section of the Company’s website at www.chembio.com. A telephone replay will be available by dialing 877-481-4010 from the US or 919-882-2331 from outside the US using passcode 28132 until 4:30pm ET on Wednesday, May 16, 2018.
Contact:
Lynn Pieper Lewis
Gilmartin Group
Investor Relations
(415) 937-5402
[email protected]
